Norcantharidin Inhibits cell growth by suppressing the expression and phosphorylation of both EGFR and c-Met in human colon cancer cells
作者: Peiju QiuSiwen WangMing LiuHe MaXuan ZengMeng ZhangLingling XuYidi CuiHuixin XuYang TangYanli HeLijuan Zhang
作者单位: 1Ocean University of China
2Affiliated Hospital of Qingdao University
刊名: BMC Cancer, 2017, Vol.17 (1)
来源数据库: Springer Journal
DOI: 10.1186/s12885-016-3039-x
关键词: NorcantharidinColon cancerCell cycleApoptosisEGFRC-Met
英文摘要: Norcantharidin (NCTD) is a Chinese FDA approved, chemically synthesized drug for cancer treatment. The effect of NCTD on signaling proteins of EGFR and c-Met was systematically elucidated in current study.
原始语种摘要: Norcantharidin (NCTD) is a Chinese FDA approved, chemically synthesized drug for cancer treatment. The effect of NCTD on signaling proteins of EGFR and c-Met was systematically elucidated in current study.
全文获取路径: Springer  (合作)
分享到:
来源刊物:
影响因子:3.333 (2012)

×
关键词翻译
关键词翻译
  • suppressing 制止的
  • cancer 癌症
  • colon 结肠
  • proteins 蛋白质
  • cells 麻风细胞
  • systematically 系统地
  • expression 表示
  • cycle 旋回
  • approved 认可的
  • human 人的